What does Colistimethate (Coly-Mycin) do in plain English—and how does it work inside your body?
Colistimethate is an FDA-regulated Polymyxin-class Antibacterial (RxNorm RxCUI RXN-42023107-3157). Mechanistically, Clinical mechanism for Colistimethate (150 mg/2mL Injection, manufactured/labeled by Par Health USA, LLC) centers on polymyxin-class antibacterial target modulation following intramuscular-route uptake, maintaining therapeutic plasma exposure across FDA-listed 42023-107 regimens. [1][2].
When your doctor writes a prescription for Colistimethate (RxNorm RxCUI RXN-42023107-3157, also dispensed under brand names including Coly-Mycin), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Clinical mechanism for Colistimethate (150 mg/2mL Injection, manufactured/labeled by Par Health USA, LLC) centers on polymyxin-class antibacterial target modulation following intramuscular-route uptake, maintaining therapeutic plasma exposure across FDA-listed 42023-107 regimens. [2].
Across real-world patient logs on dotMD (78% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Colistimethate tablet bottle and confirm with your pharmacist that it matches your prescribed strength (150 mg/2mL Injection, 150 mg/2mL).